Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Replication licensing--defining the proliferative state?

J Julian Blow1, Ben Hodgson

  • 1Cancer Research Campaign (CRC) Chromosome Replication Research Group, Wellcome Trust Biocentre, University of Dundee, Dow Street, Dundee, UK DD1 5EH. j.j.blow@dundee.ac.uk

Trends in Cell Biology
|February 19, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the impact of an Australian Virtual Care service on low-acuity presentations to district emergency departments: an interrupted time series analysis.

BMJ open·2026
Same author

Author Correction: A PP1-PP2A phosphatase relay controls mitotic progression.

Nature·2026
Same author

Geminin inhibits DNA replication licensing by sterically blocking CDT1-MCM2 interactions.

Nature communications·2025
Same author

Correction to "Development of BromoTag: A "Bump-and-Hole"-PROTAC System To Induce Potent, Rapid, and Selective Degradation of Tagged Target Proteins".

Journal of medicinal chemistry·2025
Same author

The Atad5 RFC-like complex is the major unloader of proliferating cell nuclear antigen in Xenopus egg extracts.

The Journal of biological chemistry·2023
Same author

The location and development of Replicon Cluster Domains in early replicating DNA.

Wellcome open research·2023
Same journal

Horizontal transfer of mitochondria in cancer: The physiology reborn in disease?

Trends in cell biology·2026
Same journal

Spindle errors: A stress test for epithelial robustness.

Trends in cell biology·2026
Same journal

Multicellular ecosystems: Linking cellular diversity to tissue function and disease.

Trends in cell biology·2026
Same journal

Orchestrating the signaling-bias at the protease-activated receptor, PAR1.

Trends in cell biology·2026
Same journal

Crashing by design: Utilizing DNA damage for MCC differentiation.

Trends in cell biology·2026
Same journal

The value of a shared lab: Our insights.

Trends in cell biology·2026
See all related articles

Cell proliferation relies on DNA replication control. Origin licensing, regulated by cyclin-dependent kinases (CDKs), prevents re-replication. Mcm2-7 proteins may serve as early cancer markers.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Eukaryotic cell proliferation requires precise DNA duplication each cell cycle.
  • Re-replication is prevented by the replication licensing system, which assembles Mcm2-7 protein complexes onto replication origins.
  • Cyclin-dependent kinases (CDKs) directly regulate this licensing system.

Purpose of the Study:

  • To explore the role of origin licensing in controlling cell proliferation.
  • To investigate the connection between CDK regulation and origin licensing.
  • To propose a functional distinction between proliferative and non-proliferative states based on origin licensing.

Main Methods:

  • Analysis of the regulation of the replication licensing system.
  • Investigation of cyclin-dependent kinase (CDK) control over origin licensing.

Related Experiment Videos

  • Evaluation of Mcm2-7 proteins as potential diagnostic markers.

    • Main Results:

    • Repression of origin licensing is a key mechanism for reducing cellular proliferative capacity.
    • Mcm2-Mcm7 proteins show potential as biomarkers for early-stage cancers.
    • A functional distinction between proliferative and non-proliferative (G0) states can be defined by origin licensing status.

    Conclusions:

    • Origin licensing, controlled by CDKs, is crucial for regulating cell proliferation.
    • Mcm2-7 proteins are promising diagnostic markers for early cancer detection.
    • Origin licensing status provides a basis for distinguishing proliferative from non-proliferative cells.